Peter Ghoroghchian is the founder of Ceptur Therapeutics. Ceptur Therapeutics has raised $75M in total funding. Latest round: Series A.
Peter Ghoroghchian is the co-founder, President, and Chief Executive Officer of Ceptur Therapeutics, a preclinical RNA therapeutics biotechnology company. He co-founded the company in 2021 to advance genetic medicines based on proprietary U1 Adaptor technology.
Full founder directory · Investor directory · Company funding database · Fundraising library